Almac Sciences celebrates 10 years of Analytical apprenticeships 

September 9, 2026

Almac Sciences is marking 10 years of its Analytical Higher Level Apprenticeship (HLA) programme, celebrating a decade of developing future scientific talent and supporting long-term careers in the pharmaceutical industry. 

Since its launch, the programme has grown significantly, providing successful applicants with the opportunity to combine academic study with hands-on industry experience, while contributing to real-world scientific work within Almac’s Analytical teams. The success of the programme is reflected in its impact: 

  • 51 apprentices enrolled since 2016 
  • 24 BSc (Hons) graduates 
    34 Foundation Degree graduates  
  • 50 % retained within Almac Sciences  

Helen Goodrich, Analytical Development Commercial Support Manager at Almac Sciences, said: 
“We’re incredibly proud to mark 10 years of the Analytical apprenticeship programme. Over that time, we’ve seen first-hand the impact it has on individuals; supporting them to build confidence, develop technical skills, and progress into meaningful careers within the industry. It’s also played a key role in strengthening our teams by bringing through talented individuals who understand our business and our standards from the very beginning.” 

The programme has continued to evolve over the past decade, expanding in both scale and scope while maintaining a strong focus on mentorship and practical experience. It remains a core part of Almac Sciences’ approach to investing in people and supporting the next generation of scientists. 

Stephen Barr, President and Managing Director of Almac Sciences, added: 
“Our apprenticeship programme is central to how we develop talent at Almac Sciences. Reaching this 10-year milestone is a testament to the dedication of our apprentices and the colleagues who support them. By investing in career pathways like this, we are not only creating opportunities for individuals but also strengthening the long-term capabilities of our business and the wider life sciences sector.” 

Share

Back to news